Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Hi David- My Dad has lived with Multiple Myeloma for the past 17 years. Considering the life expectancy of a person with MM is 5-7 years, I’d say my dad has done well.
Here’s the problem. We have just been told there is no more treatment out there for him. He had a stem cell 15 years ago, has received various chemotherapy regimens including:
18 years ago he started on immunotherapy called Daratumumab aka darzelex and it took his sight. My dad was completely blind within 8 months of taking it, literally in the dark.
The hospital said it was not the immunotherapy, but we knew it was darzalex that was taking my dad’s eye sight because each time he was treated with it, he lost more and more sight.
He came off the immunology, as he wanted to see. He was off it for 16 months and his sight has come back to about 80%. He then recently went on to another treatment, but his body could not take it and our news was devastating, that there is no more treatment out there.
Do you have any ideas for other therapy options? Thanks, Linda.
“This study clearly shows that curcumin nanoparticles could deliver DOX efficiently…Surprisingly, extracellular alkalization induced a 2- to 3-fold increase in the efficacy of doxorubicin…”
Before I get to the issue discussed in the subject line “Baking Soda, Curcumin, Doxorubicin as integrative multiple myeloma therapy,” I have to establish several key issues. I’ve linked four studies below. I have to explain the importance of these studies…
According to the studies linked and excerpted below:
“Compared to bortezomib/dexamethasone (BD) regimen, arsenic trioxide/bortezomib/ascorbic acid/dexamethasone (ABCD) regimen significantly improved PFS and OS in newly diagnosed patients.”
If you’ve been diagnosed with multiple myeloma (MM) and you’re considering what MM chemotherapy to do first (induction therapy), please focus on the words “significantly improved PFS and OS in newly diagnosed patients.” According to the study linked below ABCD out-performs BD as induction therapy for newly diagnosed MM patients.
Let me explain.
The three most important aspects of the study below and therefore of ABCD induction therapy is: